Weiss Ratings Daily

Sign up for free. Then check your inbox each morning for uncommon wisdom from the Weiss Ratings experts. All independent, unbiased and accurate. All grounded in our ratings of 53,000+ companies and investments. All to help grow your wealth in good times and bad.

Articles

Bitcoin ‘Decoupled’ Provides Limitless Profit Potential
By Jessica Borg On November 17, 202001:26 PM Eastern
Monumental events are defining this month: The winner of the highest office in the land has been declared and there’s a viable COVID-19 vaccine potentially coming soon — welcome news as our nation...
The Single Most Profitable Post-Election Investments
By Sean Brodrick On November 16, 202005:33 PM Eastern
TODAY AT 2 p.m. Eastern: URGENT CANNABIS INVESTOR BRIEFING with Senior Analyst Sean Brodrick and Founder Martin Weiss. For your free ticket, be sure to click here before 12 noon!  This...
Viable Vaccines & Crypto
By Jessica Borg On November 16, 202001:48 PM Eastern
Coronavirus cases in this country topped 11 million over the weekend, making today’s news from Moderna, Inc. (Nasdaq: MRNA) that much more significant. The pharmaceutical company announced its...
The Top 10 Investment Rules
By Tony Sagami On November 13, 202011:46 AM Eastern
When I was a 30-year-old newbie retail stockbroker at Merrill Lynch, I thought I knew everything. You couldn’t tell me anything. But looking back, the only thing I really knew was the sales jargon...
Are Pfizer and BioNTech the Best Pharmaceuticals to Bet on Right Now?
By Kelly Green On November 11, 202004:27 PM Eastern
I’ve said it before, and I’ll say it again … you can absolutely lose your mind by trying to follow the news these days. That’s even more true if you’re trying to use the news as a resource to time...
Is a ‘Big Shift’ in the Markets and the Economy at Hand?
By Mike Larson On November 10, 202003:37 PM Eastern
Is a “big shift” at hand? That’s the question Wall Street is wrestling with here. And, naturally, the answer will have major implications for investors. Before I offer my answer to that...
Pfizer and the ‘Vanguard of the RNA Vaccine Hunt’
By Jon D. Markman On November 9, 202004:59 PM Eastern
It’s not a bold-sentence recommendation, and it’s based on an interview conducted by a journalist for a different media outlet. It’s Jon Markman, writing in the Aug. 10 issue of Pivotal Point: ...
The 3 Election Winners That Most Investors Are Ignoring
By Martin D. Weiss, Ph.D. On November 9, 202009:43 AM Eastern
The stock market is surging dramatically this morning, celebrating the U.S. election and an announcement by Pfizer that its COVID-19 vaccine is 90% effective. But I don’t envy Joe Biden. More...
How to Invest Prudently in Chaotic Times
By Jessica Borg On November 8, 202012:48 PM Eastern
We just endured an election “season” like no other. And true to brand for 2020, even long after the last ballots were cast, drama and uncertainty persist. The backdrop continues to be a...
Lockdown Meltdown and Coronavirus Crash
By Tony Sagami On November 6, 202009:16 AM Eastern
The coronavirus crap is really getting old. And my highly unscientific polling of my friends shows a roughly equal split between those supporting lockdowns and those opposing lockdowns. ...
169171
Martin D. Weiss, Ph.D.
Weiss Ratings Founder
Chris Graebe
Contributor
Sean Brodrick
Contributor
Nilus Mattive
Contributor
Jim Nelson
Contributor
Michael A. Robinson
Contributor
Gavin Magor
Contributor

About the Editor

Dr. Weiss is the founder of Weiss Ratings, the nation’s leading provider of 100% independent grades on stocks, mutual funds and financial institutions, as well as the world’s only ratings agency that grades cryptocurrencies. He founded his company in 1971, and thanks largely to his strict independence, has established a 50-year record of accuracy. Forbes called him “Mr. Independence.” The U.S. Government Accountability Office (GAO) reported that his insurance company ratings outperformed those of A.M. Best, S&P and Moody’s by at least three to one. And The Wall Street Journal reported that investors using the Weiss stock ratings could have made more money than those following the grades issued by Merrill Lynch, J.P. Morgan, Goldman Sachs, Standard & Poor’s and every other firm reviewed.